HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Aug. 23, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that independent clinical trial results from studies of the Company's AlzheimAlert (TM) test will be presented at the XXVIIIth International Congress of Clinical Neurophysiology in Edinburgh, Scotland on September 11, 2006. The presentation will concern the use of the AlzheimAlert(TM) test in the diagnosis of mild cognitive impairment in the elderly. The authors of the paper include Ira Goodman of Orlando Regional Healthcare System, Stephen Flitman of 21st Century Neurology, Phoenix AZ, Kevin Xie of Centra Care Clinic, St. Cloud MN, Alireza Minagar of Louisiana State University Health Sciences Center, Shreveport LA and Ralph Richter of University of Oklahoma, Tulsa OK.
